Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation

doi:10.3748/wjg.v20.i43.16037

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 43

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11467)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-6) series.

Item

Count

PDF

642

WORD

306

HTML

7551

Figures (1-6)

413

Tables (1-6)

287

Sum=9199

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

984

Download

1284

Sum=2268

Nov 21, 2014 (publication date) through Jan 13, 2025

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Nov 21, 2014; 20(43): 16037-16052
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16037

Table 1 Risk factors and causes of reactivation of chronic hepatitis B

Causes of HBV reactivation	Risk factors
	Male sex
Cancer chemotherapy	Genotypes B and D
Immunosuppressants	Pre-core and core promoter mutations
Corticosteroid withdrawal	Elevated ALT at presentation
Interferon therapy
Hepatitis A/E virus superinfection
Hepatitis C virus superinfection
Hepatitis delta virus superinfection/co-infection
Interaction with HIV infection
Effect of immune reconstitution therapy

Modified from Jindal et al. Liver International (2011).

Citation: Philips CA, Sarin SK. Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation. World J Gastroenterol 2014; 20(43): 16037-16052
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16037.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16037